Histopathological and molecular characterization of tumors was achieved considering tumor grade according to 2016 WHO (48) and several biomarkers (i.e., IDH-1, TERT, MGMT, DEL1p/19q, Ki-67). This evidence concerns the gene IDH1 and neoplasm.